---
document_datetime: 2023-09-21 21:34:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ebvallo-epar-all-authorised-presentations_en.pdf
document_name: ebvallo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7233047
conversion_datetime: 2025-12-21 19:00:19.012363
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength                         | Pharmaceutical form      | Route of administration   | Immediate Packaging   | Content (concentration)   | Pack size    |
|------------------|-------------------|----------------------------------|--------------------------|---------------------------|-----------------------|---------------------------|--------------|
| EU/1/22/1700/001 | Ebvallo           | 2.8 × 10 7 - 7.3 × 10 7 cells/mL | Dispersion for injection | Intravenous use           | vial (COC)            | 1 ml                      | 1 to 6 vials |